Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 53 articles:
HTML format
Text format



Single Articles


    March 2017
  1. YANG Z, Hackshaw A, Feng Q, Fu X, et al
    Comparison of gefitinib, erlotinib and afatinib in non-small cell lung cancer: A meta-analysis.
    Int J Cancer. 2017 Mar 14. doi: 10.1002/ijc.30691.
    PubMed     Text format     Abstract available


  2. WEBER M, Yap S, Goldsbury D, Manners D, et al
    Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCOM2012 risk prediction tool.
    Int J Cancer. 2017 Mar 1. doi: 10.1002/ijc.30673.
    PubMed     Text format     Abstract available


    February 2017
  3. SHIEH JM, Tang YA, Hu FH, Huang WJ, et al
    A histone deacetylase inhibitor enhances expression of genes inhibiting Wnt pathway and augments activity of DNA demethylation reagent against non-small cell lung cancer.
    Int J Cancer. 2017 Feb 24. doi: 10.1002/ijc.30664.
    PubMed     Text format     Abstract available


  4. LIN TY, Hsu HY, Sun WH, Wu TH, et al
    Induction of Cbl-dependent epidermal growth factor receptor degradation in Ling Zhi-8 suppressed lung cancer.
    Int J Cancer. 2017 Feb 15. doi: 10.1002/ijc.30649.
    PubMed     Text format     Abstract available


    January 2017
  5. FEHRINGER G, Brenner DR, Zhang ZF, Lee YA, et al
    Alcohol and Lung Cancer Risk Among Never Smokers: A Pooled Analysis from the International Lung Cancer Consortium and the SYNERGY Study.
    Int J Cancer. 2017 Jan 24. doi: 10.1002/ijc.30618.
    PubMed     Text format     Abstract available


  6. HAN SS, Ten Haaf K, Hazelton WD, Munshi VN, et al
    The impact of overdiagnosis on the selection of efficient lung cancer screening strategies.
    Int J Cancer. 2017 Jan 10. doi: 10.1002/ijc.30602.
    PubMed     Text format     Abstract available


    December 2016
  7. ZHANG Y, Xu J, Lou Y, Hu S, et al
    Pretreatment Direct Bilirubin and Total Cholesterol Are Significant Predictors of Overall Survival in Advanced Non-small Cell Lung Cancer Patients with EGFR Mutations.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30581.
    PubMed     Text format     Abstract available


    November 2016
  8. POON CC, Kelly JJ
    Development of crizotinib, a rationally designed tyrosine kinase inhibitor for non-small cell lung cancer.
    Int J Cancer. 2016 Nov 22. doi: 10.1002/ijc.30533.
    PubMed     Text format     Abstract available


  9. NAGY A, Pongor LS, Szabo A, Santarpia M, et al
    KRAS driven expression signature has prognostic power superior to mutation status in non-small cell lung cancer.
    Int J Cancer. 2016 Nov 8. doi: 10.1002/ijc.30509.
    PubMed     Text format     Abstract available


  10. JIA M, Zhu M, Zhou F, Wang M, et al
    Genetic variants of JNK and p38alpha pathways and risk of non-small cell lung cancer in an Eastern Chinese population.
    Int J Cancer. 2016 Nov 5. doi: 10.1002/ijc.30508.
    PubMed     Text format     Abstract available


    October 2016
  11. PEREA F, Bernal M, Sanchez-Palencia A, Carretero J, et al
    The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration.
    Int J Cancer. 2016 Oct 27. doi: 10.1002/ijc.30489.
    PubMed     Text format     Abstract available


  12. WANG D, Pham NA, Tong J, Sakashita S, et al
    Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.
    Int J Cancer. 2016 Oct 17. doi: 10.1002/ijc.30472.
    PubMed     Text format     Abstract available


    September 2016
  13. OHYAMA K, Yoshimi H, Aibara N, Nakamura Y, et al
    Immune complexome analysis reveals the specific and frequent presence of immune complex antigens in lung cancer patients: A pilot study.
    Int J Cancer. 2016 Sep 29. doi: 10.1002/ijc.30455.
    PubMed     Text format     Abstract available


  14. BAGLIETTO L, Ponzi E, Haycock P, Hodge A, et al
    DNA methylation changes measured in pre-diagnostic peripheral blood samples are associated with smoking and lung cancer risk.
    Int J Cancer. 2016 Sep 15. doi: 10.1002/ijc.30431.
    PubMed     Text format     Abstract available


    August 2016
  15. HONG S, Mok Y, Jeon C, Jee SH, et al
    Tuberculosis, smoking and risk for lung cancer incidence and mortality.
    Int J Cancer. 2016 Aug 13. doi: 10.1002/ijc.30384.
    PubMed     Text format     Abstract available


  16. ZHANG Y, Breitling LP, Balavarca Y, Holleczek B, et al
    Comparison and combination of blood DNA methylation at smoking-associated genes and at lung cancer related genes in prediction of lung cancer mortality.
    Int J Cancer. 2016 Aug 9. doi: 10.1002/ijc.30374.
    PubMed     Text format     Abstract available


    July 2016
  17. WANG A, Qin F, Hedlin H, Desai M, et al
    Physical activity and sedentary behavior in relation to lung cancer incidence and mortality in older women: The Women's Health Initiative.
    Int J Cancer. 2016 Jul 20. doi: 10.1002/ijc.30281.
    PubMed     Text format     Abstract available


  18. TOMCZAK A, Miller AB, Weichenthal SA, To T, et al
    Long-term exposure to fine particulate matter air pollution and the risk of lung cancer among participants of the Canadian National Breast Screening Study.
    Int J Cancer. 2016 Jul 6. doi: 10.1002/ijc.30255.
    PubMed     Text format     Abstract available


  19. ZHAO QT, Yuan Z, Zhang H, Zhang XP, et al
    Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients.
    Int J Cancer. 2016;139:164-70.
    PubMed     Text format     Abstract available


  20. YANG M, Xu X, Cai J, Ning J, et al
    NSCLC harboring EGFR exon-20 insertions after the regulatory C-helix of kinase domain responds poorly to known EGFR inhibitors.
    Int J Cancer. 2016;139:171-6.
    PubMed     Text format     Abstract available


    June 2016
  21. WANG J, Su X, Yang L, Qiao F, et al
    The influence of myeloid-derived suppressor cells on angiogenesis and tumor growth after cancer surgery.
    Int J Cancer. 2016;138:2688-99.
    PubMed     Text format     Abstract available


    May 2016
  22. XIE K, Liang C, Li Q, Yan C, et al
    Role of ATG10 expression quantitative trait loci in non-small cell lung cancer survival.
    Int J Cancer. 2016 May 26. doi: 10.1002/ijc.30205.
    PubMed     Text format     Abstract available


    April 2016
  23. AIZAWA K, Liu C, Tang S, Veeramachaneni S, et al
    Tobacco carcinogen (NNK) induces both lung cancer and non-alcoholic steatohepatitis and hepatocellular carcinomas in ferrets which can be attenuated by lycopene supplementation.
    Int J Cancer. 2016 Apr 26. doi: 10.1002/ijc.30161.
    PubMed     Text format     Abstract available


    March 2016
  24. PIRIE K, Peto R, Green J, Reeves GK, et al
    Lung cancer in never-smokers.
    Int J Cancer. 2016 Mar 8. doi: 10.1002/ijc.30084.
    PubMed     Text format     Abstract available


    February 2016
  25. MEDER L, Konig K, Ozretic L, Schultheis AM, et al
    NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas.
    Int J Cancer. 2016;138:927-38.
    PubMed     Text format     Abstract available


    January 2016
  26. JANG YS, Kang JH, Woo JK, Kim HM, et al
    Ninjurin1 suppresses metastatic property of lung cancer cells through inhibition of Interleukin-6 signaling pathway.
    Int J Cancer. 2016 Jan 27. doi: 10.1002/ijc.30021.
    PubMed     Text format     Abstract available


  27. WANG Y, Liu H, Ready NE, Su L, et al
    Genetic variants in ABCG1 are associated with survival of non-small cell lung cancer patients.
    Int J Cancer. 2016 Jan 12. doi: 10.1002/ijc.29991.
    PubMed     Text format     Abstract available


  28. MAHALE J, Smagurauskaite G, Brown K, Thomas A, et al
    The role of stromal fibroblasts in lung carcinogenesis: A target for chemoprevention?
    Int J Cancer. 2016;138:30-44.
    PubMed     Text format     Abstract available


    December 2015
  29. ZHANG X, Ai F, Li X, She X, et al
    Inflammation-induced S100A8 activates Id3 and promotes colorectal tumorigenesis.
    Int J Cancer. 2015;137:2803-14.
    PubMed     Text format     Abstract available


  30. YAMADA K, Maishi N, Akiyama K, Towfik Alam M, et al
    CXCL12-CXCR7 axis is important for tumor endothelial cell angiogenic property.
    Int J Cancer. 2015;137:2825-36.
    PubMed     Text format     Abstract available


  31. DAL BELLO MG, Alama A, Barletta G, Coco S, et al
    Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors.
    Int J Cancer. 2015;137:2947-58.
    PubMed     Text format     Abstract available


  32. YUAN JM, Nelson HH, Butler LM, Carmella SG, et al
    Genetic determinants of cytochrome P450 2A6 activity and biomarkers of tobacco smoke exposure in relation to risk of lung cancer development in the Shanghai Cohort Study.
    Int J Cancer. 2015 Dec 13. doi: 10.1002/ijc.29963.
    PubMed     Text format     Abstract available


  33. KJAERGAARD AD, Nordestgaard BG, Johansen JS, Bojesen SE, et al
    Observational and genetic plasma YKL-40 and cancer in 96,099 individuals from the general population.
    Int J Cancer. 2015;137:2696-704.
    PubMed     Text format     Abstract available


    November 2015
  34. MINGUET J, Smith KH, Bramlage P
    Targeted therapies for treatment of non-small cell lung cancer - recent advances and future perspectives.
    Int J Cancer. 2015 Nov 4. doi: 10.1002/ijc.29915.
    PubMed     Text format     Abstract available


  35. LINET MS, Yin SN, Gilbert ES, Dores GM, et al
    A retrospective cohort study of cause-specific mortality and incidence of hematopoietic malignancies in Chinese benzene-exposed workers.
    Int J Cancer. 2015;137:2184-97.
    PubMed     Text format     Abstract available


    September 2015
  36. NILSSEN Y, Strand TE, Fjellbirkeland L, Bartnes K, et al
    Lung cancer treatment is influenced by income, education, age and place of residence in a country with universal health coverage.
    Int J Cancer. 2015 Sep 30. doi: 10.1002/ijc.29875.
    PubMed     Text format     Abstract available


  37. TAKEUCHI S, Fukuda K, Arai S, Nanjo S, et al
    Organ-specific efficacy of HSP90 inhibitor in multiple-organ metastasis model of chemorefractory small cell lung cancer.
    Int J Cancer. 2015 Sep 17. doi: 10.1002/ijc.29858.
    PubMed     Text format     Abstract available


  38. FURUGAKI K, Fukumura J, Iwai T, Yorozu K, et al
    Impact of bevacizumab in combination with erlotinib on EGFR-mutated non-small cell lung cancer xenograft models with T790M mutation or MET amplification.
    Int J Cancer. 2015 Sep 15. doi: 10.1002/ijc.29848.
    PubMed     Text format     Abstract available


  39. DAI D, Li XF, Wang J, Liu JJ, et al
    Predictive Efficacy of C-PD153035 PET Imaging for EGFR-Tyrosine Kinase Inhibitor Sensitivity in Non-small Cell Lung Cancer Patients.
    Int J Cancer. 2015 Sep 3. doi: 10.1002/ijc.29832.
    PubMed     Text format     Abstract available


    August 2015
  40. CHARKIEWICZ R, Pilz L, Sulewska A, Kozlowski M, et al
    Validation for histology driven diagnosis in non-small cell lung cancer using hsa-miR-205 and hsa-miR-21 expression by two different normalization strategies.
    Int J Cancer. 2015 Aug 27. doi: 10.1002/ijc.29816.
    PubMed     Text format     Abstract available


  41. INFANTE M, Allavena P, Garlanda C, Nebuloni M, et al
    Prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients.
    Int J Cancer. 2015 Aug 27. doi: 10.1002/ijc.29822.
    PubMed     Text format     Abstract available


  42. NERI S, Ishii G, Hashimoto H, Kuwata T, et al
    Podoplanin-expressing cancer-associated fibroblasts lead and enhance the local invasion of cancer cells in lung adenocarcinoma.
    Int J Cancer. 2015;137:784-96.
    PubMed     Text format     Abstract available


  43. WU CF, Andzinski L, Kasnitz N, Kroger A, et al
    The lack of type I interferon induces neutrophil-mediated pre-metastatic niche formation in the mouse lung.
    Int J Cancer. 2015;137:837-47.
    PubMed     Text format     Abstract available


    July 2015
  44. DENG XB, Xiao L, Wu Y, Jin F, et al
    Inhibition of mesothelioma cancer stem-like cells with adenovirus-mediated NK4 gene therapy.
    Int J Cancer. 2015;137:481-90.
    PubMed     Text format     Abstract available


  45. SEGALINY AI, Mohamadi A, Dizier B, Lokajczyk A, et al
    Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment.
    Int J Cancer. 2015;137:73-85.
    PubMed     Text format     Abstract available


  46. GANSMO LB, Knappskog S, Romundstad P, Hveem K, et al
    Influence of MDM2 SNP309 and SNP285 status on the risk of cancer in the breast, prostate, lung and colon.
    Int J Cancer. 2015;137:96-103.
    PubMed     Text format     Abstract available


    June 2015
  47. BANERJEE J, Papu John AM, Schuller HM
    Regulation of non small-cell lung cancer stem cell like cells by neurotransmitters and opioid peptides.
    Int J Cancer. 2015 Jun 18. doi: 10.1002/ijc.29646.
    PubMed     Text format     Abstract available


    May 2015
  48. BAI R, Weng C, Dong H, Li S, et al
    MicroRNA-409-3p suppresses colorectal cancer invasion and metastasis partly by targeting GAB1 expression.
    Int J Cancer. 2015 May 20. doi: 10.1002/ijc.29607.
    PubMed     Text format     Abstract available


  49. WRAGE M, Hagmann W, Kemming D, Uzunoglu FG, et al
    Identification of HERC5 and its potential role in NSCLC progression.
    Int J Cancer. 2015;136:2264-72.
    PubMed     Text format     Abstract available


  50. BUTKIEWICZ D, Krzesniak M, Drosik A, Giglok M, et al
    The VEGFR2, COX-2 and MMP-2 polymorphisms are associated with clinical outcome of patients with inoperable non-small cell lung cancer.
    Int J Cancer. 2015 May 14. doi: 10.1002/ijc.29605.
    PubMed     Text format     Abstract available


  51. HLEYHEL M, Belot A, Bouvier AM, Tattevin P, et al
    Trends in survival after cancer diagnosis among HIV-Infected Individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 Cohort.
    Int J Cancer. 2015 May 14. doi: 10.1002/ijc.29603.
    PubMed     Text format     Abstract available


    December 2014
  52. JOUVE N, Bachelier R, Despoix N, Blin MG, et al
    CD146 mediates VEGF-induced melanoma cell extravasation through FAK activation.
    Int J Cancer. 2014 Dec 2. doi: 10.1002/ijc.29370.
    PubMed     Text format     Abstract available


    October 2014
  53. OSELLA-ABATE S, Ribero S, Sanlorenzo M, Maule MM, et al
    Risk factors related to late metastases in 1,372 melanoma patients disease free more than 10 years.
    Int J Cancer. 2014 Oct 21. doi: 10.1002/ijc.29281.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: